SCHEDULE 13D/A Filed 2026-07-24 Event 2026-07-20 SEC 0001493152-26-034520 →

Choo Chee Kong → CytoMed Therapeutics Ltd GDTC

Stake: 24.30% Shares: 2,899,746 CUSIP: Y1R80M106 Class: Ordinary Shares

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 27/100

Active Schedule 13D filer baseline
High conviction ownership stake (24.3%)
Short interest building (+372.4% vs prior settlement)

Item 4 — Purpose of Transaction

Mr. Choo Chee Kong has acquired all of the Ordinary Shares beneficially owned by him (1) in exchange for capital contributions to the Issuer or (2) through public purchases on the open market with his personal funds for investment purposes. The Reporting Person serves as Chairman of the Issuer and is a member of the board of directors of the Issuer and, as a result, may be asked to vote on or discuss matters related to items (a) through (j) of this Item 4 of Schedule 13D with representatives of the Issuer and others. Except as may be set forth herein, the Reporting Person has no current intention, plan or proposal with respect to items (a) through (j) of Item 4 of Schedule 13D.

Cross-References

Insider Activity (last 365d)

2 transactions

2 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 1.07

17,102 shares short · +372.4% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-20	Choo Chee Kong	director, 10%+ owner	Buy	100,000	$1.50	$150K
2026-07-14	Choo Chee Kong	director, 10%+ owner	Buy	100,000	$1.50	$150K

Other 13D/G Filings on CytoMed Therapeutics Ltd

Filed	Form	Filer	Stake	Shares
2026-10-16	SCHEDULE 13D/A	Choo Chee Kong	25.17%	3,003,996	view →
2026-10-13	SCHEDULE 13D/A	Choo Chee Kong	24.92%	2,974,746	view →

Other Filings by Choo Chee Kong

Filed	Form	Issuer	Stake	Shares
2026-10-16	SCHEDULE 13D/A	CytoMed Therapeutics Ltd	25.17%	3,003,996	view →
2026-10-13	SCHEDULE 13D/A	CytoMed Therapeutics Ltd	24.92%	2,974,746	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →